| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 60,392 | 40,474 | 41,724 | 38,302 | | Cost of Revenue | 45,392 | 25,695 | 28,935 | 25,974 | | | Gross Profit | 15,000 | 14,779 | 12,789 | 12,328 | | | Operating Expenses | | Research Development | 3,390 | 3,687 | 4,564 | 4,169 | | Selling General and Administrative | 8,038 | 8,710 | 10,126 | 9,631 | | Non Recurring |
-
| 609 |
-
| 2,189 | | Others | 160 | 157 | 479 | 486 | | | | Total Operating Expenses |
-
| 13,163 |
-
| 16,475 | | | | Operating Income or Loss | 3,412 | 1,616 | (2,380) | (4,147) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (20) | 91 | 40 | 56 | | Earnings Before Interest And Taxes | 3,392 | 1,707 | (2,340) | (4,091) | | Interest Expense | 2 | 2 | 11 | 2 | | Income Before Tax | 3,390 | 1,705 | (2,351) | (4,093) | | Income Tax Expense | 76 | 154 | 54 | (62) | | Minority Interest |
-
|
-
|
-
| (31) | | | | Net Income From Continuing Ops | 3,314 | 1,551 | (2,405) | (4,062) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 412 | 1 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,314 | 1,551 | (1,993) | (4,061) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,314 | $1,551 | ($1,993) | ($4,061) |
|
0.33% Nasdaq 
0.29%
Income Statement
